If you have been on a therapeutic dose for at least eight weeks without any weight loss, several factors should be evaluated: medication quality (especially if using compounded formulations), caloric intake that may be too high or too low, thyroid function, sleep quality, and stress levels
Becker, Austin Taylor, Guo-Fang Zhang, Kyle W
Presented for research literature review only Yurdakk M et al
The key consideration is that retatrutide adds glucagon receptor activation that the body has never experienced with either semaglutide or tirzepatide
Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin
Geographic Disparities: Patients in rural or medically underserved areas may not have access to endocrinologists or specialized support